Novotech

Press Releases

U.S. Govt. Selects Grand River Aseptic Manufacturing to Help Combat COVID-19

Grand River Aseptic Manufacturing, a leading parenteral contract development and manufacturing organization (CDMO), has been selected by the U.S. Department of Health and Human Services and the U.S. Department of Defense to support the expansion of the United Statesโ€™...

AGC Biologics, Novavax Expand Coronavirus Vax Pact

AGC Biologics, a global biopharmaceutical CDMO, announced it has expanded its partnership with Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases. AGC Biologics is currently preparing to manufacture Matrix-Mโ„ข, the adjuvant component of Novavaxโ€™...

Moderna Announces Supply Agreement with U.S. Government for Initial 100 Million Doses of mRNA Vaccine Against COVID-19

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that the U.S. government has secured 100 million doses of mRNA-1273 as part of the U.S....

Glenmark introduces higher strength (400 mg) of FabiFlu to reduce pill burden of COVID-19 treatment

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced that it will introduce a 400 mg version of oral antiviral FabiFluยฎ, for the treatment of mild to moderate COVID-19 in India. The higher strength will improve patient compliance and...

Cherwell launches new support hub for growing Redipor prepared media distributor network

Cherwell Laboratories, specialist suppliers of environmental monitoring and process validation solutions for the pharmaceutical and related industries, has launched a Rediporยฎ prepared media distributor resource centre website. Developing this new online knowledge hub supports Cherwellโ€™s growing international distribution network...

Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine

Johnson & Johnson announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses of Janssenโ€™s SARS-CoV-2 investigational vaccine, Ad26.COV2.S, for...

Zydus Cadila announces completion of dosing in Phase I clinical trial of ZyCoV-D

Zydus Cadila, an innovation driven global pharmaceutical company focused on discovering and developing NCEs, Novel Biologicals, Biosimilars and Vaccines, announced that its plasmid DNA vaccine to prevent COVID-19, ZyCoV-D was found to be safe and well tolerated in the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป